... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Toothbrushing Nonalcoholic fatty liver disease Metabolic syndrome...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Fatty liver Epidemiology Mortality Diabetes Metabolic syndrome Obesity Nonalcoholic fatty liver disease (NAFLD...

...Benedikt A. Aulinger; Thuan To Viet; Elisa Waldmann; Klaus G. Parhofer Objective: Although obesity is associated with metabolic changes, not all obese patients are characterized by the metabolic syndrome (MS). The goal of this study was to determine the prevalence of the MS, its characteristics...

...Jia Di; Yan Cheng; Danyan Chang; Yan Liu Background and Aim: The etiology and pathogenesis of Barrett’s esophagus (BE) have been widely studied during recent decades. However, the association between BE and possible risk factors, including abdominal obesity (AO), metabolic syndrome (MetS), insulin...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Cholestasis Metabolic Syndrome Liver steatosis Nonalcoholic fatty liver disease (NAFLD) is becoming the most common liver disease worldwide with an estimated prevalence of 20–30% among...

...Christian Labenz; Vera Prenosil; Sandra Koch; Yvonne Huber; Jens U. Marquardt; Jörn M. Schattenberg; Peter R. Galle; Arndt Weinmann; Marcus-Alexander Wörns Background/Aim: Individual components of the metabolic syndrome (MS) such as obesity or diabetes mellitus impair the prognosis of patients...

... and hepatocellular carcinoma worldwide. NAFLD is considered as the hepatic manifestation of the metabolic syndrome. With the pandemic rise of obesity, the incidence of NAFLD is also further increasing, and considering the life style in modern societies, there is a significant overlap of (risk factors causing) NAFLD...

... obesity and metabolic syndrome and may be secondary to non-alcoholic steatohepatitis (NASH)-related HCC. The aims of this chapter are to (1) define the natural history of non-alcoholic fatty liver disease/NASH, (2) discuss the relationship between cryptogenic cirrhosis and NASH-related cirrhosis, (3...

... loss and increasing physical activity) and management of the features of metabolic syndrome are vital for all patients with NAFLD. Metformin is the first-line therapy for diabetic patients with NAFLD and also reduces the risk of hepatocellular carcinoma. Clinicians should have a low threshold...

...E. Scarpellini; J. Tack Obesity causes chronic low-grade inflammation that contributes to systemic metabolic dysfunction associated with obesity-linked disorders that fall under the definition of metabolic syndrome. Adipose tissue is a key endocrine organ as it releases multiple bioactive...

... Metabolic syndrome Obesity-related cancer Obesity-related digestive disease Epidemic trends The definition of obesity as established by the World Health Organization is solely a BMI (body mass index, calculated as body mass in kg divided by the square of the height in meters) >30, individuals...

..., such as irritable bowel syndrome, inflammatory bowel disease, metabolic syndrome, obesity, and cancer. 12 12 2011 © 2011 S. Karger AG, Basel 2011 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced...

... is associated with (components of) the metabolic syndrome. Obesity, diabetes and hepatic steatosis are also independent risk factors for hepatic fibrosis in different chronic liver diseases. However, the question is whether it is actually nonalcoholic steatohepatitis and not ‘simple’ steatosis that promotes...

.... The pathophysiological significance of hepatic lipid accumulation in the absence of significant alcohol consumption is also increasingly recognized. Non-alcoholic fatty liver disease (NAFLD) is regarded as the hepatic manifestation of the metabolic syndrome, and it is the most common cause of liver enzyme elevations...

... predictors of type 2 diabetes and cardiovascular disease than obesity alone. Some of these metabolic abnormalities, which are either causes or consequences of insulin resistance, have been called the metabolic syndrome. Fat accumulation in the liver due to non-alcoholic causes (non-alcoholic fatty liver...

... of liver fibrosis, which can progress to cirrhosis. Hepatocellular carcinoma can develop in patients with NASH, even in the absence of cirrhosis. The majority of patients with primary NASH exhibit risk factors that define the metabolic syndrome including insulin resistance and visceral obesity. However...

... of the metabolic syndrome, a systemic subclinical inflammatory state. Conclusion: The introduction of a positive criterion also mentioned in its definition would benefit the diagnosis of NAFLD and of steatohepatitis observed in the setting of other liver diseases, help to estimate the risk of its progression...

... of related conditions. Treatment of these conditions must be tailored according to patient’s features. Conclusions: The clinical significance of FL is incompletely understood at present. The relationship, if any, of FL and the metabolic syndrome should be carefully investigated. Atherosclerosis Cancer...